250 related articles for article (PubMed ID: 34875964)
1. Relationship between attitudes toward the effectiveness of vaccine, concerns about adverse reactions, and proactively taking SARS-Cov-2 vaccine for family among medical workers in Taizhou, China.
Luo C; Zhang MX; Shi GF; Chen HX; Tung TH
Expert Rev Vaccines; 2022 Feb; 21(2):269-275. PubMed ID: 34875964
[TBL] [Abstract][Full Text] [Related]
2. Willingness to pay for booster dose of COVID-19 vaccine among healthcare workers in Taizhou,China.
Pan SJ; Yang YP; Zhang MX; Tung TH
Hum Vaccin Immunother; 2022 Nov; 18(5):2063629. PubMed ID: 35522922
[TBL] [Abstract][Full Text] [Related]
3. Willingness to receive SARS-CoV-2 vaccine among healthcare workers in public institutions of Zhejiang Province, China.
Wang J; Feng Y; Hou Z; Lu Y; Chen H; Ouyang L; Wang N; Fu H; Wang S; Kan X; Liao Y; Lu G; Mao J; Lin J; Wu M
Hum Vaccin Immunother; 2021 Sep; 17(9):2926-2933. PubMed ID: 33848217
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Adverse Reactions to an Inactivated SARS-CoV-2 Vaccine Among Medical Staff in China.
Zhu JS; Zhang MX; Chien CW; Yang WY; Shi GF; Qiu S; Tung TH; Chen HX
Front Med (Lausanne); 2021; 8():731593. PubMed ID: 34568389
[No Abstract] [Full Text] [Related]
6. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
Expert Rev Vaccines; 2022 Feb; 21(2):261-267. PubMed ID: 34894991
[TBL] [Abstract][Full Text] [Related]
7. Post-vaccination adverse reactions, decision regret, and willingness to pay for the booster dose of COVID-19 vaccine among healthcare workers: A mediation analysis.
Luo C; Jiang W; Chen HX; Tung TH
Hum Vaccin Immunother; 2022 Nov; 18(6):2146964. PubMed ID: 36422511
[TBL] [Abstract][Full Text] [Related]
8. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia.
Enticott J; Gill JS; Bacon SL; Lavoie KL; Epstein DS; Dawadi S; Teede HJ; Boyle J;
BMJ Open; 2022 Jan; 12(1):e057127. PubMed ID: 34980631
[TBL] [Abstract][Full Text] [Related]
9. Integrating health behavior theories to predict American's intention to receive a COVID-19 vaccine.
Chu H; Liu S
Patient Educ Couns; 2021 Aug; 104(8):1878-1886. PubMed ID: 33632632
[TBL] [Abstract][Full Text] [Related]
10. From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign.
Wang J; Zhu H; Lai X; Zhang H; Huang Y; Feng H; Lyu Y; Jing R; Guo J; Fang H
Expert Rev Vaccines; 2022 Mar; 21(3):385-395. PubMed ID: 34974779
[TBL] [Abstract][Full Text] [Related]
11. Characterizing initial COVID-19 vaccine attitudes among pregnancy-capable healthcare workers.
Perez MJ; Paul R; Raghuraman N; Carter EB; Odibo AO; Kelly JC; Foeller ME
Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100557. PubMed ID: 34952227
[TBL] [Abstract][Full Text] [Related]
12. Changes in attitudes to vaccination as a result of the COVID-19 pandemic: A longitudinal study of older adults in the UK.
Gallant AJ; Nicholls LAB; Rasmussen S; Cogan N; Young D; Williams L
PLoS One; 2021; 16(12):e0261844. PubMed ID: 34941951
[TBL] [Abstract][Full Text] [Related]
13. A Cross-Sectional Survey on COVID-19 Vaccine Hesitancy Among Parents From Shandong vs. Zhejiang.
Xu Y; Xu D; Luo L; Ma F; Wang P; Li H; Li Q; Wei L; Diao J; Liu Y; Zhang W; Zheng X
Front Public Health; 2021; 9():779720. PubMed ID: 34805084
[No Abstract] [Full Text] [Related]
14. Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease.
Zhang E; Gupta A; Al-Ani A; Macrae FA; Leong RW; Christensen B
Can J Gastroenterol Hepatol; 2022; 2022():4527844. PubMed ID: 36124090
[TBL] [Abstract][Full Text] [Related]
15. Attitudes of Healthcare Professionals and General Population Toward Vaccines and the Intention to Be Vaccinated Against COVID-19 in Spain.
Iguacel I; Luna Maldonado A; Luna Ruiz-Cabello A; Samatán E; Alarcón J; Ángeles Orte M; Santodomingo Mateos S; Martínez-Jarreta B
Front Public Health; 2021; 9():739003. PubMed ID: 34692626
[No Abstract] [Full Text] [Related]
16. Tracking Public Attitudes Toward COVID-19 Vaccination on Tweets in Canada: Using Aspect-Based Sentiment Analysis.
Jang H; Rempel E; Roe I; Adu P; Carenini G; Janjua NZ
J Med Internet Res; 2022 Mar; 24(3):e35016. PubMed ID: 35275835
[TBL] [Abstract][Full Text] [Related]
17. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
Casas Fischer R
Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Expression Differences Between Professionals and Laypeople Toward the COVID-19 Vaccine: Text Mining Approach.
Luo C; Ji K; Tang Y; Du Z
J Med Internet Res; 2021 Aug; 23(8):e30715. PubMed ID: 34346885
[TBL] [Abstract][Full Text] [Related]
20. Kidney transplant recipients' attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance.
Tharmaraj D; Dendle C; Polkinghorne KR; Mulley WR
Transpl Infect Dis; 2022 Feb; 24(1):e13749. PubMed ID: 34694682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
